RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Austar Lifesciences Stock

Austar Lifesciences Net Income 2024

Austar Lifesciences Net Income

-113.47 M CNY

Ticker

6118.HK

ISIN

KYG0632L1023

In 2024, Austar Lifesciences's profit amounted to -113.47 M CNY, a -229.74% increase from the 87.46 M CNY profit recorded in the previous year.

The Austar Lifesciences Net Income history

YEARNET INCOME (undefined CNY)
2023-113.47
202287.46
2021277.3
202033.1
20198.09
20180.11
2017-54.09
2016-18.67
20156.38
201465.19
201353.6
201235.5
201127.3

Austar Lifesciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Austar Lifesciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Austar Lifesciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Austar Lifesciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Austar Lifesciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Austar Lifesciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Austar Lifesciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Austar Lifesciences’s growth potential.

Austar Lifesciences Revenue, EBIT and net profit per share

DateAustar Lifesciences RevenueAustar Lifesciences EBITAustar Lifesciences Net Income
20231.76 B undefined-41.42 M undefined-113.47 M undefined
20222.16 B undefined122.73 M undefined87.46 M undefined
20212.02 B undefined117.52 M undefined277.3 M undefined
20201.3 B undefined26.59 M undefined33.1 M undefined
20191.05 B undefined7.79 M undefined8.09 M undefined
2018816.59 M undefined-6.02 M undefined107,000 undefined
2017546.93 M undefined-68.12 M undefined-54.09 M undefined
2016672.55 M undefined-20.53 M undefined-18.67 M undefined
2015627.54 M undefined3.2 M undefined6.38 M undefined
2014679.75 M undefined84.65 M undefined65.19 M undefined
2013705.2 M undefined71.9 M undefined53.6 M undefined
2012420.8 M undefined48.7 M undefined35.5 M undefined
2011325.2 M undefined36.1 M undefined27.3 M undefined

Austar Lifesciences stock margins

The Austar Lifesciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Austar Lifesciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Austar Lifesciences.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Austar Lifesciences's sales revenue. A higher gross margin percentage indicates that the Austar Lifesciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Austar Lifesciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Austar Lifesciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Austar Lifesciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Austar Lifesciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Austar Lifesciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Austar Lifesciences Margin History

Austar Lifesciences Gross marginAustar Lifesciences Profit marginAustar Lifesciences EBIT marginAustar Lifesciences Profit margin
202319.05 %-2.35 %-6.43 %
202222.66 %5.69 %4.05 %
202123.77 %5.83 %13.76 %
202024.96 %2.05 %2.55 %
201927.1 %0.74 %0.77 %
201825.03 %-0.74 %0.01 %
201722.22 %-12.45 %-9.89 %
201623.75 %-3.05 %-2.78 %
201524.58 %0.51 %1.02 %
201433.63 %12.45 %9.59 %
201330.49 %10.2 %7.6 %
201232.41 %11.57 %8.44 %
201130.9 %11.1 %8.39 %

Austar Lifesciences Aktienanalyse

What does Austar Lifesciences do?

Austar Lifesciences Ltd is an Indian manufacturer of pharmaceutical products and medical devices. The company was founded in 2003 by Mr. Sudhir Taneja and is headquartered in the city of Mohali in the state of Punjab. Since its inception, the company has continuously evolved and is now a leading brand in the Indian healthcare market. Austar Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Austar Lifesciences's Profit Margins

The profit margins of Austar Lifesciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Austar Lifesciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Austar Lifesciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Austar Lifesciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Austar Lifesciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Austar Lifesciences stock

How much profit has Austar Lifesciences made this year?

Austar Lifesciences has made -113.47 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by -229.74% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Austar Lifesciences publish its earnings?

Austar Lifesciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Austar Lifesciences?

The profits of Austar Lifesciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Austar Lifesciences?

You can learn more about the earnings of Austar Lifesciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Austar Lifesciences pay?

Over the past 12 months, Austar Lifesciences paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 8.52 %. For the coming 12 months, Austar Lifesciences is expected to pay a dividend of 0 CNY.

What is the dividend yield of Austar Lifesciences?

The current dividend yield of Austar Lifesciences is 8.52 %.

When does Austar Lifesciences pay dividends?

Austar Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Austar Lifesciences?

Austar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Austar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Austar Lifesciences located?

Austar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Austar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Austar Lifesciences from 6/26/2015 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 5/19/2015.

When did Austar Lifesciences pay the last dividend?

The last dividend was paid out on 6/26/2015.

What was the dividend of Austar Lifesciences in the year 2023?

In the year 2023, Austar Lifesciences distributed 0 CNY as dividends.

In which currency does Austar Lifesciences pay out the dividend?

The dividends of Austar Lifesciences are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Austar Lifesciences

Our stock analysis for Austar Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Austar Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.